drugset / Trial / NCT04502017
Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion
RandomizedParallel-groupOpen-labelPrevention
Summary
Comparison among three different antithrombotic strategies after percutaneous LAA occlusion with a Watchman FLX LAAC device.
Timeline
- Start
- 2020-08-05
- Primary completion
- 2022-12-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ASA | Unknown | 81 mg | — |
| Comparator | ASA | Unknown | 325 mg | — |
| Comparator | Clopidogrel | Small molecule | 75 mg | — |